Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Soloway

Showing results (91-100 of 252) with videos related to

Pageof 26
Sort By:
European Urology|July 24, 2007
Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk?Peter J Bostrom, Mark S Soloway
Current Urology Reports|October 22, 2015
Expectant Management of Low-Risk Bladder CancerZachary L Smith, Mark S Soloway
European Urology|August 11, 2020
The Fallacy of "Definitive Therapy" for Prostate CancerMark S Soloway, Soum D Lokeshwar
Nature Reviews. Urology|November 6, 2009
Brachytherapy-based bladder sparing alternative to cystectomyElie Antebi, Murugesan Manoharan, Mark S Soloway
BJU International|June 13, 2009
Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcomeMurugesan Manoharan, Rajinikanth Ayyathurai, Mark S Soloway
The Journal of Urology|March 26, 2002
Contemporary management of stage T1 transitional cell carcinoma of the bladderMark S Soloway, Mario Sofer, Anil Vaidya
Urology|March 15, 2006
The diagnosis and staging of bladder cancer: from RBCs to TURsAdrienne J K Carmack, Mark S Soloway
Urologic Oncology|March 23, 2013
Active surveillance for low-risk bladder cancerAlbert Tiu, Lawrence C Jenkins, Mark S Soloway
Postgraduate Medicine|June 14, 2012
Diagnosis and treatment of bladder cancer: how can we improve?Michael A Gorin, Rajinikanth Ayyathurai, Mark S Soloway
Indian Journal of Urology : IJU : Journal of the Urological Society of India|October 25, 2011
Budd-Chiari syndrome in urology: Impact on nephrectomy for advanced renal cell carcinomaSamir P Shirodkar, Mark S Soloway, Gaetano Ciancio
Pageof 26

Showing results (91-100 of 252) with videos related to

Sort By:
Pageof 26
European Urology|July 24, 2007
Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk?Peter J Bostrom, Mark S Soloway
Current Urology Reports|October 22, 2015
Expectant Management of Low-Risk Bladder CancerZachary L Smith, Mark S Soloway
European Urology|August 11, 2020
The Fallacy of "Definitive Therapy" for Prostate CancerMark S Soloway, Soum D Lokeshwar
Nature Reviews. Urology|November 6, 2009
Brachytherapy-based bladder sparing alternative to cystectomyElie Antebi, Murugesan Manoharan, Mark S Soloway
BJU International|June 13, 2009
Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcomeMurugesan Manoharan, Rajinikanth Ayyathurai, Mark S Soloway
The Journal of Urology|March 26, 2002
Contemporary management of stage T1 transitional cell carcinoma of the bladderMark S Soloway, Mario Sofer, Anil Vaidya
Urology|March 15, 2006
The diagnosis and staging of bladder cancer: from RBCs to TURsAdrienne J K Carmack, Mark S Soloway
Urologic Oncology|March 23, 2013
Active surveillance for low-risk bladder cancerAlbert Tiu, Lawrence C Jenkins, Mark S Soloway
Postgraduate Medicine|June 14, 2012
Diagnosis and treatment of bladder cancer: how can we improve?Michael A Gorin, Rajinikanth Ayyathurai, Mark S Soloway
Indian Journal of Urology : IJU : Journal of the Urological Society of India|October 25, 2011
Budd-Chiari syndrome in urology: Impact on nephrectomy for advanced renal cell carcinomaSamir P Shirodkar, Mark S Soloway, Gaetano Ciancio
Pageof 26